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Objective: to study the association between the ankle±brachial pressure index (ABPI), premature death and the need for
surgical treatment for lower limb ischaemia.
Design: population based cohort study.
Subjects: three hundred and fifty-three men and women, 50±89 years old, underwent a leg pain questionnaire and
measurement of ABPI and was then followed for 10 years.
Outcome Measures: all cause mortality, vascular procedures and major amputations.
Results: a low ABPI was independently associated with premature all cause mortality in the multiple regression analysis,
carrying a relative risk of 3.4 (95% confidence interval 2.0±5.9) and 2.1 (1.3±3.3) for ABPIs 0.50 and 0.51±0.80,
respectively, compared to those with ABPI 1.0. Individuals with an ABPI in the interval 0.81±0.99 suffered only a
slight, not statistically significant risk increase compared to normals. A low ABPI at baseline implied a continuous constant
increased risk of death throughout the study period. The same risk was observed among elderly (70±89, median 77 years),
and in the middle aged (50±69, median 63 years) individuals. The vast majority of those subjected to vascular intervention
or major amputation during follow-up had an ABPI 0.8 at baseline (83 and 89%, respectively). However, within that
group, the individual ABPI was not predictive for surgical intervention.
Conclusion: the association found between an ABPI 0.8 and premature mortality in this cohort of symptomatic subjects
implies that the ABPI is a powerful, independent predictor for premature death. The prognostic information carried by an
ABPI in the interval 0.81±0.99 remains uncertain. Septuagenarians and octogenarians carry the same risk increase
associated with a low ABPI as those in the middle ages.
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Several studies have demonstrated that individuals
with a symptomatic or asymptomatic reduction in
ankle±brachial pressure index (ABPI) are at increased
risk of premature cardiovascular death.1±7 It has been
suggested that a low ABPI should prompt risk factor
intervention.8,9 However, it remains unclear what
ABPI cut off level should be used for this purpose.
Further, most of the data have been gathered from
middle aged individuals and much less is
known about the elderly (470 years).10,11 The presentPlease address all correspondence to: B. JoÈnsson, Department of
Cardiovascular Surgery & Anesthesia, University Hospital, S-58185
LinkoÈping, Sweden.
1078±5884/02/050405 06 $35.00/0 # 2002 Elsevier Science Ltd. Allpopulation-based study examines the relationship
between claudication, ABPI and mortality.
Material
In 1989, all the inhabitants of Vadstena community,
Sweden, aged between 50±89 years of age, were sent
a modified Rose Questionnaire on claudication12 com-
bined with questions about concomitant diseases. The
response rate was 92% (2557 of 2748). Individuals that
reported leg pain on walking were invited for non-
invasive testing, and 80% attended (353 out of 441).
The diagnosis of symptomatic leg ischaemia was con-
firmed when the ankle±brachial pressure index (ABPI)
was less than or equal to 0.8.13 The present studyrights reserved.




The systolic blood pressures were recorded from the
dorsalis pedis and the posterior tibial arteries with a
hand-held 8 MHz Doppler probe and a 12-cm stand-
ard cuff. The higher of the two pressures in each leg
was recorded, and the value from the worst leg was
used. The systolic ankle pressure was divided by
the brachial systolic pressure recorded in the right
arm to produce the ABPI. One specially trained
nurse performed all measurements under standar-
dised conditions.
Follow-up
Data on mortality and surgical procedures were
updated on all individuals at the end of follow-up,
which was exactly 120 months after the date of non-
invasive testing. Data on mortality was collected from
the Patient Administrative system (PAS) of the County
of OÈ stergoÈtland and from the Death Cause Registry,
The National Board of Health and Welfare in Sweden.
Information regarding vascular procedures and major
amputations were collected from PAS and from the
Swedish Vascular Registry (SwedVasc), which is a
national quality registry for open and endovascular
procedures due to peripheral arterial disease, with a




Angina pectoris, myocardial infarction: answered in the
affirmative.
Hypertension: on medical treatment for hypertension.
Cerebrovascular disease: report of any cerebrovascular
thromboembolic episode.
Diabetes: on diet regimen or pharmacological treat-
ment for diabetes mellitus.
Smoking: active smoker or exsmoker.
Surgical procedures
Vascular reconstructive procedure: any open surgical or
endovascular procedure due to leg arterial occlusive
disease.
Major amputation: amputation above ankle level.Eur J Vasc Endovasc Surg Vol 24, November 2002Statistics
Categorical variables were analysed by Chi-squared-
analysis with Yates' correction for continuity, or by
Fisher's exact test when appropriate. Mean values
were compared using the Student's t-test for inde-
pendent samples, and by calculating the 95% confi-
dence interval for the difference. When comparing
mean values in more than two groups, one way analy-
sis of variance was used. For non-normally distributed
data, the Mann±Whitney U-test was used. All tests
were two-sided and a p-value of less than 0.05 was
considered statistically significant.
Cox proportional hazards model was used to calcu-
late relative hazards and their 95% confidence inter-
vals for the influence of covariates on mortality (age,
sex, hypertension, angina pectoris, myocardial infarc-
tion, cerebrovascular incident, diabetes and smoking
were all introduced in the analysis). In the year by
year analysis of the remaining relative hazard for
death associated with a low ABPI at baseline, a new
model was calculated for each year of observation,
excluding those who died during the preceding year.
In these calculations, the stepwise method was uti-
lised. All covariates except age were categorical. Miss-
ing values in questions on concurrent diseases were
treated as answered in the negative in the analyses.
Comparisons of the frequencies of reconstructive vas-
cular surgery and major amputations at different
levels of ABPI were performed with life table tech-
nique, and the log rank test was used for significance
testing of differences between groups. All statistical




Characteristics of those 353 who had ABPI measure-
ments at baseline by univariate analysis are displayed
in Table 1. When all baseline covariates were intro-
duced in a Cox regression analysis, age, sex, ABPI,
angina pectoris, cerebrovascular disease and diabetes
were statistically significantly associated with mortal-
ity (Table 2).
Subjects were divided into two age groups, 50±69
years (median 63 years) and 70±89 years (median
77 years). To examine the impact of low ABPI on
mortality, a Cox regression model was created for
each year of follow-up, excluding those that died dur-
ing the preceding years, in order to calculate the rela-
tive hazard for death during the remaining follow-up
Table 1. Baseline characteristics of study population stratified by ABPI at first examination.
ABPI 1.00
(reference)
ABPI 0.81±0.99 p ABPI 0.80 p
n 133 113 107
Age, mean (SD) 67.1 (9.4) 68.5 (9.1) 0.22 71.8 (8.3) 50.001
Males % 57 38 0.14 57 0.11
Hypertension % 31 32 0.86 53 50.001
Angina pectoris % 20 29 0.08 45 50.001
Myocardial infarction % 8 9 0.70 25 50.001
Cardiac ischaemia% 21 32 0.06 48 50.001
Cerebrovascular disease % 3 4 0.82 9 50.05
Diabetes % 10 13 0.39 29 50.001
Active smokers % 13 18 0.28 28 50.01
Exsmokers % 20 24 0.50 27 0.22
History of angina pectoris and/or myocardial infarction at baseline.
Table 2. Covariates in the Cox regression, with death within
10 years of follow-up as outcome variable. Exponents for b






Age, per 5 years 1.59 1.41±1.79 50.001
Male vs. female sex 1.95 1.32±2.87 50.001
Hypertension 1.17 0.81±1.67 0.40
Angina pectoris 1.73 1.20±2.51 50.01
Myocardial infarction 1.28 0.80±2.04 0.30
Cerebrovascular disease 2.02 1.14±3.59 50.05
Diabetes 1.55 1.05±2.29 50.05
Active smoker 0.91 0.56±1.48 0.71
Exsmoker 0.82 0.52±1.29 0.39
ABPI
1.0 Reference
0.91±0.99 1.32 0.73±2.37 0.35
0.81±0.90 1.15 0.66±2.01 0.62
0.51±0.80 2.05 1.28±3.27 50.01
0.50 3.38 1.95±5.86 50.001
Fig. 1. The relative risk for death for those with an ABPI 0.8
compared to those with ABPI 1.0 calculated with the Cox propor-
tional hazards model, and with adjustments for other covariates
(age, sex, concomittant diseases (see Table 2) and smoking). Those
with ABPI 0.81±0.99 excluded. Each diamond point represents the
relative death hazard during the rest of the follow-up, calculated at
the beginning of the actual observation year. From year two and
forward, those who died during the previous year(s) are excluded.
Bars represent the 95% confidence intervals. Dotted lines equal
relative hazard 1, i.e. no risk difference. Upper diagram: all sub-
jects, n 240. Lower diagram: subjects 70±89 year old, n 119.
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Relative hazards associated with an ABPI 0.8 com-
pared to  1.0 were calculated for the whole popula-
tion, and separately for those 70±89 years of age
(Fig. 1). In both analyses, the lower limit of the 95%
confidence interval of the relative hazard associated
with an ABPI 0.8 was found to be above 1
(1 identical risk) for each year of follow-up except
the tenth. When both age groups were included, the
relative hazard for death was 2±3 in each, except for
the last year of follow-up. In those 70±89 years old, a
risk at the same magnitude was seen throughout the
study period. This implies that a low ABPI at baseline
still, up to 9 years later, is a significant risk marker for
premature death, also in those 470 years.
Mean loss of lifetime was calculated for men and
women in the two age groups and at different levels of
ABPI at baseline. In comparison to those with a nor-
mal ankle±brachial pressure index, the most promin-
ent relative loss of lifetime for those with ABPI 0.8Eur J Vasc Endovasc Surg Vol 24, November 2002
Table 3. Mean loss of life time (months) compared to those with ABPI 1.0 during 10 years of follow-up.
Age ABPI 0.81±0.99 ABPI 0.80
n Lost months 95% c.i. p n Lost months 95% c.i. p
Men 50±69 20 0 28 20.6 5.6±35.5 50.01
70±89 18 14.6 ÿ9.0±38.1 0.22 29 27.9 4.4±51.4 0.05
Women 50±69 43 4.3 ÿ3.9±12.5 0.30 13 4.3 ÿ4.6±13.3 0.34
70±89 32 5.5 ÿ8.6±19.6 0.44 37 32.9 17.0±48.5 0.001
Table 4. Deaths/100 person years (p.y.).
Age 50±69 70±89
n Median age Deaths Deaths/100 p.y. n Median age Deaths Deaths/100 p.y.
ABPI
 1.0 80 63 12 1.6 53 75 25 5.5
0.91±0.99 32 63 5 1.6 21 77 12 7.8
0.81±0.90 31 64 6 2.1 29 75 14 5.8
0.51±0.80 30 63 11 4.2 44 78 33 12.0
 0.50 11 66 9 13.5 22 78 21 17.3
408 B. JoÈnsson and T. Skauwas seen among elderly women (70±89 years old) and
among men at all ages. A less pronounced decrease in
ABPI did not show any statistically significant differ-
ences in any of the groups (Table 3). Death rates were
calculated for subgroups of ABPI, and only those with
low (0.51±0.8) or very low (0.5) indices differed sub-
stantially from normal levels in terms of deaths/per-
son-years (Table 4).
Local disease
A total of 18 individuals among the 353 in the study
population were subjected to vascular surgical inter-
ventions due to leg ischaemia. The mean age of these
did not differ from the rest of the study population
(68.4 vs. 69.0). Fifteen had a baseline ABPI 0.8, cor-
responding to an incidence of 20.7/1000 person-years
in this group. Incidence for those with ABPI 0.81±0.99
and those with ABPI 1 were 2.0 and 0.8, respectively.
Among those with the lowest index at baseline, the
majority of the procedures (11/15, 73%) were per-
formed during the first 2 years of follow-up, while
those recruited from the other groups had their treat-
ments during the last 4 years. In the group with
ABPI 0.8, those treated with vascular intervention
had a slightly, not significantly lower ABPI at baseline
than those who were not (median 0.5 vs. 0.65;
p 0.13).
Major amputations were performed in 8 individuals
in the low index group (incidence rate 11.1/1000
person-years) compared to one and null in thoseEur J Vasc Endovasc Surg Vol 24, November 2002with ABPI 0.81±0.99 (incidence rate 1.0) and  1.0,
respectively. The amputees in the group with
ABPI 0.8 were older than the non-amputees (73.2
vs. 68.9 years), but their ABPI did not differ signifi-
cantly (median 0.49 vs. 0.64; p 0.11). The distribu-
tions of procedures over time with stratification for
different ABPI levels are presented in Figures 2 and 3.
Discussion
The ability of the ABPI to predict death in symp-
tomatic and asymptomatic subjects seems irrefut-
able.8,9 The present study with ten years of complete
follow-up of 353 individuals confirm this impression.
The relative risk for death associated with an
ABPI 0.8 was two- to threefold compared to those
with normal ABPI levels.
This was true for patients under and over 70 years
of age and suggests that intervention such as anti-
platelet therapy15,16 and statines17 are likely to be
beneficial.
Cause of death was not analyzed in the present
study,18 although studies have reported that most
deaths are cardiovascular.
Reconstructive surgery was mainly performed in
the first 4 years of follow-up in those with
ABPI 0.8. This suggests that only a minority of sub-
jects with a low ABPI detoriate early, while most have
stable limb ischaemia, not requiring vascular interven-
tion or amputation.3,19,20 Among individuals with
an ABPI 0.8, those who were subjected to surgical
Fig. 3. Life table diagram showing the distribution of major amputations at different levels of ABPI. The group with ABPI 0.81±0.99 contains
one event at 119 months. Among those with ABPI 1.0 there were no events. Solid line: ABPI 0.8. For overall comparison p5 0.001.
Fig. 2. Life table diagram showing the distribution of vascular reconstructive procedures due to leg ischaemia at different levels of ABPI.
Solid line: ABPI 0.8; dashed line: ABPI 0.81±0.99; dotted line: ABPI 1.0. For overall comparision p 0.0001.
Ankle±brachial Index and Mortality 409intervention did not differ from those who did not,
with respect to the ABPI.
In several follow-up surveys, mortality has been
shown to correlate inversively with ABPI at base-
line.2,6,10,20 Most often, all ABPI values up to a certaincut off level are put together in one group, and then
compared to normal levels of the ABPI. Due to the
severely increased risk in individuals with a very low
ABPI, even a cut off near 1.0 could render the study
group a significantly increased mortality compared toEur J Vasc Endovasc Surg Vol 24, November 2002
410 B. JoÈnsson and T. Skaunormals. The ABPI cut off point for active risk factor
intervention is of great importance.22 In the present
study, no significant excess mortality risk was found
for individuals with an ABPI above 0.8.
The data from other studies are inconclusive.2,6,10,22
It is yet to be proven that a cut off at 0.9 is not too high,
or at 0.8 is not too low and larger population studies
are needed.
We recommend that all individuals with an ankle±
brachial pressure index at or less than 0.8, irrespective
of age, should be subjected to risk factor investigation.
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